Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, March 1, 2023
[ Wed, Mar 01st 2023
] - WOPRAI
[ Wed, Mar 01st 2023
] - WOPRAI
[ Wed, Mar 01st 2023
] - WOPRAI
[ Wed, Mar 01st 2023
] - WOPRAI
[ Wed, Mar 01st 2023
] - WOPRAI
[ Wed, Mar 01st 2023
] - WOPRAI
[ Wed, Mar 01st 2023
] - WOPRAI
[ Wed, Mar 01st 2023
] - WOPRAI
[ Wed, Mar 01st 2023
] - WOPRAI
[ Wed, Mar 01st 2023
] - WOPRAI
[ Wed, Mar 01st 2023
] - WOPRAI
[ Wed, Mar 01st 2023
] - WOPRAI
[ Wed, Mar 01st 2023
] - WOPRAI
[ Wed, Mar 01st 2023
] - WOPRAI
[ Wed, Mar 01st 2023
] - WOPRAI
[ Wed, Mar 01st 2023
] - WOPRAI
[ Wed, Mar 01st 2023
] - WOPRAI
[ Wed, Mar 01st 2023
] - WOPRAI
[ Wed, Mar 01st 2023
] - WOPRAI
[ Wed, Mar 01st 2023
] - WOPRAI
[ Wed, Mar 01st 2023
] - WOPRAI
[ Wed, Mar 01st 2023
] - WOPRAI
[ Wed, Mar 01st 2023
] - WOPRAI
[ Wed, Mar 01st 2023
] - WOPRAI
[ Wed, Mar 01st 2023
] - WOPRAI
[ Wed, Mar 01st 2023
] - WOPRAI
[ Wed, Mar 01st 2023
] - WOPRAI
[ Wed, Mar 01st 2023
] - WOPRAI
[ Wed, Mar 01st 2023
] - WOPRAI
[ Wed, Mar 01st 2023
] - WOPRAI
Nathan Rich Maintained (XRAY) at Hold with Increased Target to $39 on, Mar 1st, 2023
Nathan Rich of Goldman Sachs, Maintained "DENTSPLY SIRONA Inc." (XRAY) at Hold with Increased Target from $34 to $39 on, Mar 1st, 2023.
Nathan has made no other calls on XRAY in the last 4 months.
There are 3 other peers that have a rating on XRAY. Out of the 3 peers that are also analyzing XRAY, 2 agree with Nathan's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Jason Bednar of "Piper Sandler" Maintained at Hold with Increased Target to $35 on, Monday, February 6th, 2023
- Brandon Vazquez of "William Blair" Upgraded from Sell to Hold on, Thursday, January 12th, 2023
This is the rating of the analyst that currently disagrees with Nathan
- Erin Wright of "Morgan Stanley" Maintained at Buy with Decreased Target to $39 on, Tuesday, November 15th, 2022
